KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Inventory (2020 - 2023)

Ginkgo Bioworks Holdings' Inventory history spans 4 years, with the latest figure at $70000.0 for Q3 2023.

  • For Q3 2023, Inventory fell 98.81% year-over-year to $70000.0; the TTM value through Sep 2023 reached $70000.0, down 98.81%, while the annual FY2022 figure was $4.4 million, 29.8% up from the prior year.
  • Inventory reached $70000.0 in Q3 2023 per DNA's latest filing, down from $391000.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $8.7 million in Q1 2022 to a low of $70000.0 in Q3 2023.
  • Average Inventory over 4 years is $4.0 million, with a median of $3.4 million recorded in 2021.
  • Peak YoY movement for Inventory: surged 68.68% in 2022, then crashed 98.81% in 2023.
  • A 4-year view of Inventory shows it stood at $2.7 million in 2020, then increased by 22.88% to $3.4 million in 2021, then grew by 29.8% to $4.4 million in 2022, then crashed by 98.4% to $70000.0 in 2023.
  • Per Business Quant, the three most recent readings for DNA's Inventory are $70000.0 (Q3 2023), $391000.0 (Q2 2023), and $2.5 million (Q1 2023).